IQVIA and Veeva Systems announced a global clinical and commercial collaboration and the complete resolution of all pending legal disputes. The collaboration is for a long-term agreement; customers can utilize software, data, technology, service offerings, etc., from Veeva and IQVIA together in a simple and efficient manner.
How the collaboration between IQVIA and Veeva will benifit:
- Commercial: The companies have formed master data with software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other’s software or services in customer instances, including the use of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI.
- Clinical: This partnership will benefit clinical data management, clinical technology solutions, as well as EDC programming expertise with Veeva software to foster database builds, study locks, and data delivery.
IQVIA is a prominent global provider of clinical research services, commercial insights as well as healthcare intelligence to the life sciences and healthcare industries. The company is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.
Similarly, Veeva is the global provider of cloud software for the life sciences industry. Focused on innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs.
Executive Statement
According to Ari Bousbib, chairman and CEO of IQVIA, IQVIA and Veeva’s partnerships will bring together best-in-class capabilities in information, AI, technology, along with services for their shared clients. This will also enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients.
